Changes in Seizure Frequency and Antiepileptic Therapy during Pregnancy
NEJM 383:2547-2556, Pennell, P.G.,et al, 2020
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age with Epilepsy
JAMA Neurol 76:783-790, Kim, H.,et al, 2019
Risk of 23 Specific Malformations Associated with Prenatal Exposure to 10 Antiepileptic Drugs
Neurol 93:e167-e180, Blotiere, P.O.,et al, 2019
Declining Malformation Rates with Changed Antiepileptic Drug Prescribing, An Observational Study
Neurol 93:e831-e840, Tomson,T.,et al, 2019
Maternal and Fetal Risks of Natalizumab Exposure in Utero
Neurol 90:443-444, Marrie, R.A.,et al, 2018
Diagnosis and Management of the Antiphospholipid Syndrome
NEJM 378:2010-2021, Garcia, D. & Erkan, D., 2018
Pregnancy, Hormonal Treatments for Infertility, Contraception, and Menopause in Women After Ischemic Stroke
Stroke 48:501-506, Caso, V.,et al, 2017
Maternal Use of antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children
JAMA 318:1700-1701, Bromley, R.L.,et al, 2017
Neonatal Abstinence Syndrome
NEJM 375:2468-2479, McQueen, K. & Murphy-Oikonen, J., 2016
Triptans for Symptomatic Treatment of Migraine Headache
BMJ 348:g2285, Pringsheim, T. & Becker, W.J., 2014
Use of Antiepileptic Drugs during Pregnancy and Risk of Spontaneous Abortion and Stillbirth: Population Based Cohort Study
BMJ 349:g5159, Bech, B.H.,et al, 2014
Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
JAMA 309:1696-1703, Christensen, J.,et al, 2013
Early Child Development and Exposure to Antiepileptic Drugs Prenatally and Through Breastfeeding
JAMA Neurol 70:1367-1374, Veiby, G.,et al, 2013
Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:1158-1192, Saposnik,G.,et al, 2011
Bacterial Meningitis in the United States, 1998-2007
NEJM 364:2016-25, Thigpen, M.C.,et al, 2011
Folic Acid Supplements in Pregnancy and Severe Language Delay in Children
JAMA 36:1566-1573, Roth, C.,et al, 2011
Triptan Therapy in Migraine
NEJM 363:63-70, Loder,E., 2010
Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations
NEJM 362:2185-2193, Jentink,J., et al, 2010
Intrauterine Exposure to Carbamazepine and Specific Congenital Malformations: Systematic Review and Case-Control Study
BMJ 341:c6581, 1229, Jentik,J.,et al, 2010
Pregnancy and Fetal Outcomes After Interferon-b Exposure in Multiple Sclerosis
Neurol 75:1794-1802, Amato,M.P.,et al, 2010
Relapse Management in Multiple Sclerosis
The Neurologist 15:1-5, Thrower,B.W., 2009
Cognitive Function at 3 Years of Age After Fetal Exposure to Antiepileptic Drugs
NEJM 360:1597-1605,1667, Meador,K.J.,et al, 2009
Headache and Pregnancy
The Neurologist 14:108-119, Menon,R. &Bushnell,C.D., 2008
Topiramate in Pregnancy: Preliminary Experience From the UK Epilepsy and Pregnancy Register
Neurol 71:272-276, Unt,S.,et al., 2008
Does Lamotrigine Use in Pregnancy Increase Orofacial Cleft Risk Relative to Other Malformations?
Neurol 71:714-722, Dolk,H.,et al., 2008
The SANAD Study of Effectiveness of Valproate,Lamotrigine,or Topiramate for Generalised and Unclassifiable Epilepsy:An Unblinded Randomised Controlled Trial
Lancet 369:1016-1026, Marson,A.G.,et al, 2007
Epilepsy in Pregnancy
BMJ 335:769-774, Tomson,T. &Hiilesmaa,V., 2007
Malformation Risks of Antiepileptic Drugs in Pregnancy: A Prospective Study from the UK Epilepsy and Pregnancy Register
JNNP 77:193-198,145, Morrow,J.,et al, 2006
Seizure Control and Treatment in Pregnancy, Observations from the EURAP Epilepsy Pregnancy Registry
Neurol 66:354-360, The EURAP Study Group, 2006
Preeclampsia and the Risk of Ischemic Stroke Among Young Women
Stroke 37:1055-1059, Brown,D.W.,et al, 2006
In Utero Antiepileptic Drug Exposure: Fetal Death and Malformations
Neurol 67:407-412, Meador,K.J.,et al, 2006
Teratogenicity of Antiepileptic Drugs
BMJ 333:615-616, Breen,D.P. &Davenport,R.J., 2006
Levetiracetam in Pregnancy: Preliminary Experience From the UK Epilepsy and Pregnancy Register
Neurol 67:1876-1879, Hung,S.,et al, 2006
Increased Rate of Major Malformations in Offspring Exposed to Valproate Durng Pregnancy
Neurol 64:961-965, 938, Wyszynski,D.F., et al, 2005
Lamotrigine and the Risk of Malformations in Pregnancy
Neurol 64:955-960, 938, Cunnington, M. , et al, 2005
Pregnancy Outcomes During Treatment with Interferon Beta-1a in Patients with Multiple Sclerosis
Neurol 65:802-806, Sandberg-Wollheim,M.,et al, 2005
The AED (Antiepileptic Drug) Pregnancy Registry
Arch Neurol 61:673-678, Holmes,L.B.,et al, 2004
Restless Legs Syndrome
NEJM 348:2103-2109, Earley,C.J., 2003
The Safety of Triptans in the Treatment of Patients with Migraine
Am J Med 112:135-140, Jamieson,D.G., 2002
Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
Impact of Folic Acid Fortification of the US Food Supply on the Occurrence of Neural Tube Defects
JAMA 285:2981-2986,3022, Honein,M.A.,et al, 2001
Folic Acid Antagonists During Pregnancy and the Risk of Birth Defects
NEJM 343:1608-1614, Hernandez-Dias,S.,et al, 2000
Maternal Thyroid Deficiency During Pregnancy and Subsequent Neuropsychological Development of the Child
NEJM 341:549-555,601, Haddow,J.E.,et al, 1999
Folic Acid for the Prevention of Neural Tube Defects
Pediartrics 104:325-327, Committee on Genetics, 1999
Migraine in Pregnancy
Neurol 53:S26-S28, Aube,M., 1999
Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999
Neural-Tube Defects
NEJM 341:1509-1519,1485, Botto,L.D.,et al, 1999
Intravenous Immunoglobulin Treatment in Multiple Sclerosis, Effect on Relapses
Neurol 50:398-402, Achiron,A.,et al, 1998
Rate of Pregnancy-Related Relapse in Multiple Sclerosis
NEJM 339:285-291, 3391998., Confavreux,C.,et al, 1998